Kezar Life Sciences (KZR) Return on Capital Employed (2022 - 2025)
Historic Return on Capital Employed for Kezar Life Sciences (KZR) over the last 4 years, with Q2 2025 value amounting to 0.74%.
- Kezar Life Sciences' Return on Capital Employed fell 1100.0% to 0.74% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.74%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 0.56% for FY2024, which is 1000.0% down from last year.
- Latest data reveals that Kezar Life Sciences reported Return on Capital Employed of 0.74% as of Q2 2025, which was down 1100.0% from 0.72% recorded in Q1 2025.
- In the past 5 years, Kezar Life Sciences' Return on Capital Employed ranged from a high of 0.22% in Q3 2022 and a low of 0.74% during Q2 2025
- Over the past 4 years, Kezar Life Sciences' median Return on Capital Employed value was 0.46% (recorded in 2023), while the average stood at 0.46%.
- In the last 5 years, Kezar Life Sciences' Return on Capital Employed crashed by -300bps in 2023 and then crashed by -2800bps in 2024.
- Quarter analysis of 4 years shows Kezar Life Sciences' Return on Capital Employed stood at 0.24% in 2022, then tumbled by -110bps to 0.51% in 2023, then crashed by -32bps to 0.68% in 2024, then dropped by -9bps to 0.74% in 2025.
- Its Return on Capital Employed stands at 0.74% for Q2 2025, versus 0.72% for Q1 2025 and 0.68% for Q4 2024.